Protection of vincristine-induced neuropathy by Wld^S expression and the independence of the activity of Nmnat1WATANABE, Masashi; TSUKIYAMA, Tadasuke; HATAKEYAMA, Shigetsugu et al.Neuroscience letters. 2007, Vol 411, Num 3, pp 228-232, issn 0304-3940, 5 p.Article

Extravasación de vincristina = Extravasation of VincristineOJEDA, T; GARCIA-BRAVO, B; CAMACHO, F. M et al.Actas dermo-sifiliográficas (Ed. impresa). 2010, Vol 101, Num 6, pp 560-561, issn 0001-7310, 2 p.Article

Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degenerationRAVULA, Surendra K; WANG, Min S; MCCLAIN, Maxine A et al.Neuroscience letters. 2007, Vol 415, Num 1, pp 34-39, issn 0304-3940, 6 p.Article

The Study of Improved Controlled Release of Vincristine Sulfate from Collagen-Chitosan Complex FilmHONGLI CHEN; HAN CHEN; LINGRONG LIU et al.Artificial cells, blood substitutes, and biotechnology. 2008, Vol 36, Num 4, pp 372-385, 14 p.Article

THE CHEMOTHERAPY OF ADVANCED SQUAMOUS CELL CARCINOMAS: LONG TERM RESULTS OBTAINED WITH A COMBINATION OF METHOTREXATE, THE VINCA ALKALOIDS AND BLEOMYCINTURNER RL; WARD AJ.1982; CLIN. RADIOL.; ISSN 0009-9260; GBR; DA. 1982; VOL. 33; NO 1; PP. 101-108; BIBL. 19 REF.Article

Kinetics of micronucleated polychromatic erythrocyte (MN-PCE) induction in vivo by aneuploidogensMORALES-RAMIREZ, Pedro; VALLARINO-KELLY, Teresita; CRUZ-VALLEJO, Virginia et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2004, Vol 565, Num 1, pp 79-87, issn 1383-5718, 9 p.Article

A microarray based expression profiling of paclitaxel and vincristine resistant MCF―7 cellsKARS, Meltem Demirel; ISERI, Ozlem Darcansoy; GÜNDÜZ, Ufuk et al.European journal of pharmacology. 2011, Vol 657, Num 1-3, pp 4-9, issn 0014-2999, 6 p.Article

Vincristine, an efficacious alternative for diffuse neonatal haemangiomatosisPEREZ-VALLE, S; PEINADOR, M; HERRAIZ, P et al.Acta paediatrica (Oslo). 2010, Vol 99, Num 2, pp 311-315, issn 0803-5253, 5 p.Article

Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetinVAN ZANDEN, Jelmer J; DE MUL, Anika; WORTELBOER, Heleen M et al.Biochemical pharmacology. 2005, Vol 69, Num 11, pp 1657-1665, issn 0006-2952, 9 p.Article

Profound destructive effects of adolescent exposure to vincristine accompanied with some sex differences in motor and memory performanceSHABANI, Mohammad; MOHAMMAD HASSAN LARIZADEH; PARSANIA, Shahrnaz et al.Canadian journal of physiology and pharmacology. 2012, Vol 90, Num 4, pp 379-386, issn 0008-4212, 8 p.Article

Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agentsWEI LIANG; HAILONG XIA; JING LI et al.Cytotechnology (Dordrecht). 2011, Vol 63, Num 5, pp 523-530, issn 0920-9069, 8 p.Article

Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia : An in vivo studyVERRILLS, Nicole M; LIEM, Natalia L; LIAW, Tracy Y. E et al.Proteomics (Weinheim. Print). 2006, Vol 6, Num 5, pp 1681-1694, issn 1615-9853, 14 p.Article

SYNERGISTIC EFFECT OF RICIN IN COMBINATION WITH DAUNORUBICIN, CIS-DICHLORODIAMMINEPLATINUM (II) A,D VINCRISTINE IN SYSTEMIC L 1210 LEUKEMIAFODSTAD O; PIHL A.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 6; PP. 2152-2158; BIBL. 22 REF.Article

Quantification of Vincristine and its Major Metabolite in Human Plasma by High-Performance Liquid Chromatography/Tandem Mass SpectrometryDENNISON, Jennifer B; RENBARGER, Jamie L; WALTERHOUSE, David O et al.Therapeutic drug monitoring. 2008, Vol 30, Num 3, pp 357-364, issn 0163-4356, 8 p.Article

Indole synthesis: a review and proposed classificationTABER, Douglass F; TIRUNAHARI, Pavan K.Tetrahedron (Oxford. Print). 2011, Vol 67, Num 38, issn 0040-4020, 7185, 7195-7210 [17 p.]Article

Republished paper: The quest to eliminate intrathecal vincristine errors: a 40-year journeyNOBLE, Douglas J; DONALDSON, Liam J.Postgraduate medical journal. 2011, Vol 87, Num 1023, pp 71-74, issn 0032-5473, 4 p.Article

Vincristine-loaded platelets for immune thrombocytopeniaWEIGERT, Oliver; WITTMANN, Georg; GRÜTZNER, Stephanie et al.Thrombosis and haemostasis. 2010, Vol 104, Num 2, pp 418-419, issn 0340-6245, 2 p.Article

The controlled release study of Vincristine SulfateYONG SUN; XU, Lisa; QIQING ZHANG et al.Artificial cells, blood substitutes, and biotechnology. 2003, Vol 31, Num 1, pp 81-88, 8 p.Article

ERSTE ERFAHRUNGEN MIT ADRIAMYCIN, EINEM NEUEN ZYTOTOXISCHEN ANTIBIOTIKUM, IN DER KOMBINATIONSCHEMOTHERAPIE MALIGNER TUMOREN = LES PREMIERS RESULTATS OBTENUS AVEC L'ADRIAMYCINE, UN NOUVEL ANTIBIOTIQUE CYTOTOXIQUE DANS LA CHIMIOTHERAPIE ASSOCIEE DES TUMEURS MALIGNESJUNGI WF; MAYR AC; SMITH P et al.1972; SCHWEIZ. MED. WSCHR.; SCHWEIZ.; DA. 1972; VOL. 102; NO 34; PP. 1213-1221; ABS. ANGL.; BIBL. 26REF.Serial Issue

Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestationsCOFRANCESCO, E; CORTELLARO, M; POGLIANI, E et al.Acta haematologica. 1984, Vol 72, Num 1, pp 21-25, issn 0001-5792Article

DOUBLE LABELING AUTORADIOGRAPHY: CELL KINETIC STUDIES WITH ³H- AND ¹⁴C-THYMIDINESCHULTZE B.1981; J. HISTOCHEM. CYTOCHEM.; ISSN 0022-1554; USA; DA. 1981; VOL. 29; NO 1; SUPPL.; PP. 109-116; BIBL. 18 REF.Article

EFFECTS OF VINCRISTINE ON NORMAL AND STIMULATED MEGAKARYOCYTOPOIESIS IN THE RAT = EFFETS DE LA VINCRISTINE SUR LA MEGACARYOCYTOPOIESE NORMALE ET ACTIVEE CHEZ LE RATEBBE S; HOWARD D; PHALEN E et al.1975; BRIT. J. HAEMATOL.; G.B.; DA. 1975; VOL. 29; NO 4; PP. 593-603; BIBL. 1P.Article

VINCA-ALKALOIDE IN DER INNEREN MEDIZIN = LES ALCALOIDES DE V. EN MEDECINE INTERNEOBRECHT P.1972; PLANTA MED.; ALLEM.; DA. 1972; VOL. 22; NO 3; PP. 334-335; ABS. ANGL.Serial Issue

KINETIC STUDIES OF THE MURINE FOETAL THYMUS USING VINCRISTINE SULPHATERICHES AC; CARR HMH; MCQUEEN L et al.1981; VIRCHOWS ARCH., B; ISSN 0340-6075; DEU; DA. 1981; VOL. 37; NO 3; PP. 297-307; BIBL. 2 P.Article

VINCRISTINE-INDUCED ORTHOSTATIC HYPOTENTION: A PROSPECTIVE CLINICAL STUDYDIBELLA NJ.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 2-3; PP. 359-360; BIBL. 4 REF.Article